TomoTherapy announces first Middle East installation of Hi‰Û¢Art cancer treatment system

183

Saudi Arabia’s King Faisal Specialist Hospital & Research Centre will become region’s first to treat cancer patients with next-generation radiation therapy solution.

TomoTherapy has recently announced that Saudi Arabia’s leading cancer centre, King Faisal Specialist Hospital & Research Centre (KFSH&RC), in Riyadh, will become the region’s first to treat patients with the Hi•Art treatment system, a next-generation radiation therapy solution designed to improve the precision of cancer care.


The company says the Hi•Art treatment system is unique among radiation therapy devices in its computed tomography (CT) scanner-based design. The system allows clinicians to efficiently acquire a true CT image of the patient immediately before daily treatment to help ensure accuracy. Then, using the same equipment as used in imaging, the treatment team can deliver highly-precise radiation in a continuous, 360-degree (helical) pattern.


KFSH&RC commemorated the installation of the Hi•Art treatment system with a ribbon-cutting ceremony during a scientific meeting held at the hospital March 9-12, 2009. The meeting, entitled “Innovative Approaches in Radiotherapy: Beyond Tomorrow”, attracted radiation oncology professionals from throughout the country and featured an impressive roster of speakers, including TomoTherapy co-founder and Chairman of the Board Thomas “Rock” Mackie.


“It was an honour for me to attend both the scientific meeting and Hi•Art system opening ceremony hosted by King Faisal Specialist Hospital & Research Centre,” said Dr. Mackie. “TomoTherapy is extremely pleased to partner with this world-renowned centre as it implements the only solution designed to deliver on the promises of image-guided, intensity-modulated radiation therapy (IG-IMRT).”